MyFinsight
Home
Blog
About
Trade accounts
receivable, net
$2,497K
(-49.39%↓ Y/Y)
Inventories
$2,155K
(13.06%↑ Y/Y)
Prepaid and other
current assets
$1,145K
(-17.15%↓ Y/Y)
Restricted cash and cash
equivalents
$285K
Property and equipment,
gross
$535K
(0.56%↑ Y/Y)
Total current assets
$6,082K
(-32.20%↓ Y/Y)
Intangible asset, net (note
7)
$869K
(-81.66%↓ Y/Y)
Property and equipment,
net
$412K
(-2.83%↓ Y/Y)
Operating lease
right-of-use assets
$118K
(-44.86%↓ Y/Y)
Other noncurrent
assets
$41K
(13.89%↑ Y/Y)
Less accumulated
depreciation
$123K
(13.89%↑ Y/Y)
Total assets
$7,522K
(-47.70%↓ Y/Y)
Accumulated deficit
-$914,019K
(-1.73%↓ Y/Y)
Accumulated other
comprehensive loss
-$5,385K
(-110.68%↓ Y/Y)
Total liabilities,
convertible and redeemable...
$7,522K
(-47.70%↓ Y/Y)
Total stockholders
deficit
-$87,516K
(-25.71%↓ Y/Y)
Additional paid-in capital
$831,875K
(0.05%↑ Y/Y)
Common stock, 0.0001
par value...
$13K
(8.33%↑ Y/Y)
Total liabilities
$90,012K
(13.63%↑ Y/Y)
Convertible and redeemable
preferred stock
$5,026K
(5.01%↑ Y/Y)
Total current
liabilities
$88,615K
(19.92%↑ Y/Y)
Contingent liabilities -
noncurrent (note 7)
$1,393K
(-73.37%↓ Y/Y)
Operating lease
liabilities noncurrent
$4K
(-95.51%↓ Y/Y)
Convertible notes-Adjuvant
Notes
$34,010K
(6.50%↑ Y/Y)
Convertible notes-Baker
Bros Notes
$18,616K
(26.24%↑ Y/Y)
Accounts payable
$12,150K
(-1.15%↓ Y/Y)
Other current
liabilities
$11,171K
(47.20%↑ Y/Y)
Derivative liabilities
$6,913K
(230333.33%↑ Y/Y)
Accrued compensation
$2,177K
(-32.99%↓ Y/Y)
Accrued expenses
$1,571K
(-52.78%↓ Y/Y)
Convertible notes-Related
Party
$1,219K
(3382.86%↑ Y/Y)
Short-term debt
$362K
(-5.48%↓ Y/Y)
Contingent liabilities -
current (note 7)
$312K
(46.48%↑ Y/Y)
Operating lease
liabilities current
$114K
(-8.06%↓ Y/Y)
Back
Back
Balance Sheet
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)
source: myfinsight.com